Dennis W Raisch

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. ncbi request reprint Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in new Mexico
    Xian Shen
    University of New Mexico, 1 University of New Mexico, MSC 09 5360, Albuquerque, NM 87131
    J Manag Care Pharm 20:579-87. 2014
  2. doi request reprint Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature
    Dennis W Raisch
    Univeristy of New Mexico, College of Pharmacy, University of New Mexico, MSC 09 5360, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 13:15-23. 2014
  3. doi request reprint Health-related quality of life changes associated with buprenorphine treatment for opioid dependence
    Dennis W Raisch
    University of New Mexico, Albuquerque, NM, USA
    Qual Life Res 21:1177-83. 2012
  4. pmc Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial
    Dennis W Raisch
    University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Cardiovasc Diabetol 11:35. 2012
  5. doi request reprint Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication
    Dennis W Raisch
    University of New Mexico, College of Pharmacy, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 10:521-8. 2011
  6. doi request reprint Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature
    Dennis W Raisch
    College of Pharmacy, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Pharmacotherapy 29:988-92. 2009
  7. ncbi request reprint Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation
    Heather M Campbell
    Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, University of New Mexico College of Pharmacy, Albuquerque, NM, USA
    IRB 30:6-14. 2008
  8. doi request reprint Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs
    Vishvas Garg
    University of New Mexico, College of Pharmacy, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 12:299-307. 2013
  9. ncbi request reprint Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    J Am Pharm Assoc (2003) 45:23-32. 2005
  10. pmc Life-threatening dermatologic adverse events in oncology
    Alyx C Rosen
    aDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York bDepartment of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico cVeterans Affairs Cooperative Studies Program, Albuquerque, New Mexico dDepartment of Dermatology eRobert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois fDepartment of Internal Medicine, Division of Dermatology, Washington University School of Medicine, St Louis, Missouri, USA
    Anticancer Drugs 25:225-34. 2014

Detail Information

Publications33

  1. ncbi request reprint Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in new Mexico
    Xian Shen
    University of New Mexico, 1 University of New Mexico, MSC 09 5360, Albuquerque, NM 87131
    J Manag Care Pharm 20:579-87. 2014
    ..Between 2004 and 2010, the New Mexico Pharmaceutical Care Foundation (NMPCF) provided a pharmacist-led tobacco cessation program to residents in New Mexico. ..
  2. doi request reprint Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature
    Dennis W Raisch
    Univeristy of New Mexico, College of Pharmacy, University of New Mexico, MSC 09 5360, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 13:15-23. 2014
    ....
  3. doi request reprint Health-related quality of life changes associated with buprenorphine treatment for opioid dependence
    Dennis W Raisch
    University of New Mexico, Albuquerque, NM, USA
    Qual Life Res 21:1177-83. 2012
    ..Few studies have described improvement in health-related quality of life (HRQOL) associated with opioid dependence treatment with buprenorphine (ODT-B)...
  4. pmc Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial
    Dennis W Raisch
    University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Cardiovasc Diabetol 11:35. 2012
    ..We assessed relationships between HU and FT values and patient demographics and clinical variables...
  5. doi request reprint Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication
    Dennis W Raisch
    University of New Mexico, College of Pharmacy, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 10:521-8. 2011
    ..The authors' purpose was to summarize published case reports and describe ARs from taxanes reported to the Food and Drug Administration (FDA) with a focus on use of package insert-specified prophylactic premedications (PPMs)...
  6. doi request reprint Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature
    Dennis W Raisch
    College of Pharmacy, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Pharmacotherapy 29:988-92. 2009
    ..001), but not probenecid. The underlying mechanism of thrombocytopenia with these drugs is unknown. Clinicians should be aware that the use of oseltamivir and probenecid has been reported to be associated with thrombocytopenia...
  7. ncbi request reprint Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation
    Heather M Campbell
    Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, University of New Mexico College of Pharmacy, Albuquerque, NM, USA
    IRB 30:6-14. 2008
  8. doi request reprint Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs
    Vishvas Garg
    University of New Mexico, College of Pharmacy, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 12:299-307. 2013
    ....
  9. ncbi request reprint Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    J Am Pharm Assoc (2003) 45:23-32. 2005
    ..To assess the perceptions and attitudes of pharmacists and pharmacy technicians involved in an office-based opioid dependence treatment program using buprenorphine/naloxone...
  10. pmc Life-threatening dermatologic adverse events in oncology
    Alyx C Rosen
    aDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York bDepartment of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico cVeterans Affairs Cooperative Studies Program, Albuquerque, New Mexico dDepartment of Dermatology eRobert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois fDepartment of Internal Medicine, Division of Dermatology, Washington University School of Medicine, St Louis, Missouri, USA
    Anticancer Drugs 25:225-34. 2014
    ..Proactive pharmacovigilance to detect and define safety signals serves to aid oncology practitioners in the recognition of possible, yet uncommon, serious, and/or life-threatening skin reactions. ..
  11. doi request reprint Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review
    Yan Cheng
    Department of Pharmacy Practice and Administrative Sciences, Pharmacoeconomics, Epidemiology, and Pharmaceutical Policy and Outcomes Research, College of Pharmacy, University of New Mexico, MSC 09 5360, 2502 Marble Avenue, NE, Albuquerque, NM 87131, USA
    Res Social Adm Pharm 9:311-29. 2013
    ..The U.S. population of racial/ethnic minorities continues to increase; however, health disparities and poor health outcomes among many of them continue to be a major public health problem confronting the U.S. health care system...
  12. doi request reprint Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes
    Heather M Campbell
    VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, United States University of New Mexico College of Pharmacy, Albuquerque, NM, United States Electronic address
    Diabetes Res Clin Pract 102:233-41. 2013
    ....
  13. ncbi request reprint A comparison of veteran and nonveteran motivations and reasons for participating in clinical trials
    Heather M Campbell
    University of New Mexico College of Pharmacy, 2502 Marble, Albuquerque, NM 87131 0001, USA
    Mil Med 172:27-30. 2007
    ..Study delays often occur due to lack of recruitment. This study's primary objective was to compare veteran and nonveteran motivations and reasons...
  14. doi request reprint A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group
    Jeff J Guo
    University of Cincinnati Health Academic Center, College of Pharmacy, Cincinnati, OH, USA
    Value Health 13:657-66. 2010
    ..Our purpose is to identify and describe published quantitative RBA methods for pharmaceuticals...
  15. doi request reprint Depressive symptoms in patients with type 2 diabetes mellitus: do stress and coping matter?
    Bijal M Shah
    College of Pharmacy, Touro University, Vallejo, CA 94592, USA
    Stress Health 28:111-22. 2012
    ..Implications of the findings and the need for longitudinal studies to evaluate these relationships are discussed...
  16. ncbi request reprint Incidence and impact of adverse drug events in pediatric inpatients
    Mark T Holdsworth
    College of Pharmacy, University of New Mexico, 2502 Marble NE, Albuquerque, NM 87131 5691, USA
    Arch Pediatr Adolesc Med 157:60-5. 2003
    ..To determine the incidence and causes of adverse drug events (ADEs) and potential ADEs in hospitalized children, and to examine the consequences of these events...
  17. ncbi request reprint Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA
    Value Health 6:158-66. 2003
    ..The purpose of this study was to compare health-care resource utilization and outcomes among children treated for low-risk febrile neutropenia (FN) in a hospital-based setting with those treated in a home-care-based setting...
  18. ncbi request reprint Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296
    Stuart S Winter
    Department of Pediatrics, Albuquerque, New Mexico 87131, USA
    Pediatr Blood Cancer 46:179-86. 2006
    ....
  19. ncbi request reprint Pain and distress from bone marrow aspirations and lumbar punctures
    Mark T Holdsworth
    Pharmacy and Pediatrics, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131 1066, USA
    Ann Pharmacother 37:17-22. 2003
    ..To compare the efficacy of 3 different pharmacologic regimens to relieve pain and distress in children with cancer undergoing bone marrow aspirations (BMAs) and lumbar punctures (LPs)...
  20. ncbi request reprint Acute and delayed nausea and emesis control in pediatric oncology patients
    Mark T Holdsworth
    Department of Pharmacy and Pediatrics, College of Pharmacy, University of New Mexico, Albuquerque, 87131, USA
    Cancer 106:931-40. 2006
    ..The current study was undertaken to determine the effectiveness of standard antiemetic interventions among children receiving emetogenic chemotherapy...
  21. ncbi request reprint Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients
    Mark T Holdsworth
    College of Pharmacy, MSC09 5360, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    Pediatrics 120:1058-66. 2007
    ..This study was conducted to determine the impact of a computerized physician order entry system with substantial decision support on the incidence and types of adverse drug events in hospitalized children...
  22. doi request reprint A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening
    Vishvas Garg
    Pharmacoeconomics, Epidemiology, Pharmaceutical Policy and Outcomes Research PEPPOR Program, Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA
    Expert Rev Pharmacoecon Outcomes Res 13:327-42. 2013
    ..Further cost-effectiveness analyses reflecting latest clinical practice and current perspectives regarding adverse outcomes of potentially unnecessary treatment are required, especially from the US government perspective...
  23. ncbi request reprint GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs
    Crystal L Harris
    Pharmaceutical Management and Research, Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM 87106 4180, USA
    Ann Pharmacother 40:1924-31. 2006
    ..Patients at risk may not be prescribed protective therapies that might mitigate their risk of NSAID-associated GI complications...
  24. ncbi request reprint Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model
    Heather M Campbell
    Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    Ann Pharmacother 41:1101-10. 2007
    ..Prevention of cardiovascular disease (CVD) events by initiating an angiotensin-converting enzyme (ACE) inhibitor on diagnosis of type 2 diabetes may increase survival and decrease costs...
  25. doi request reprint Use of number needed to treat in cost-effectiveness analyses
    Vishvas Garg
    Pharmacoeconomics, Epidemiology, Pharmaceutical Policy, and Outcomes Research program, Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA
    Ann Pharmacother 47:380-7. 2013
    ..To review the use of number needed to treat (NNT) and/or number needed to harm (NNH) values to determine their relevance in helping clinicians evaluate cost-effectiveness analyses (CEAs)...
  26. doi request reprint Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments
    Stuart R Warren
    VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, 2401 Centre Ave SE, Albuquerque, NM 87106, USA
    Clin Trials 10:441-8. 2013
    ..Counting unused study medication is the predominant method by which adherence is assessed in outpatient clinical trials but it has limitations that include questionable validity and burdens on research personnel...
  27. ncbi request reprint Opioid dependence treatment, including buprenorphine/naloxone
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, 2401 Centre, SE, Albuquerque, NM 87106 4180, USA
    Ann Pharmacother 36:312-21. 2002
    ..To review opioid dependence (OD) and its treatment. Pharmacologic treatments, including the use of buprenorphine/naloxone, are presented. Pharmaceutical care functions for outpatient OD treatment are discussed...
  28. ncbi request reprint Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program
    Mike R Sather
    VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Research and Development, Albuquerque, New Mexico, USA
    Control Clin Trials 24:570-84. 2003
    ....
  29. ncbi request reprint The role of the pharmacy coordinating center in the DIG trial
    Carol L Fye
    Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, VA Medical Center, Albuquerque, New Mexico 87106 4180, USA
    Control Clin Trials 24:289S-297S. 2003
    ..As a direct result of involvement in the DIG trial, the PCC identified the need for an increased emphasis on computerization and automated support of clinical trials, especially LSTs...
  30. doi request reprint Relationship between diet, exercise habits, and health status among patients with diabetes
    Heather M Campbell
    VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    Res Social Adm Pharm 7:151-61. 2011
    ..Similarly, diets rich in fruits or vegetables (5-13 servings) have been found to lower the risk of stroke, cardiovascular conditions, cancer, and diabetes...
  31. doi request reprint Depressive symptoms in patients with type 2 diabetes in the ambulatory care setting: opportunities to improve outcomes in the course of routine care
    Bijal M Shah
    College of Pharmacy, Touro University, Vallejo, CA 94592, USA
    J Am Pharm Assoc (2003) 48:737-43. 2008
    ....
  32. doi request reprint Determinants of nonmedical use, abuse or dependence on prescription drugs, and use of substance abuse treatment
    Vishal Bali
    Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, 1441 Moursund St, Houston, TX 77030, USA
    Res Social Adm Pharm 9:276-87. 2013
    ..However, effect of health insurance in the specific subgroups of population is largely unknown...
  33. ncbi request reprint Direct health care costs of 4 common skin ulcers in New Mexico Medicaid fee-for-service patients
    Ritesh N Kumar
    College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
    Adv Skin Wound Care 17:143-9. 2004
    ..To determine health care costs associated with pressure ulcers, ulcers of the lower limbs, other chronic ulcers, and venous leg ulcers from the New Mexico Medicaid fee-for-service program perspective...